Literature DB >> 23850106

Reduced thalamic volumes in major depressive disorder.

Allison Carol Nugent1, Rebecca Marie Davis, Carlos Alberto Zarate, Wayne Curtis Drevets.   

Abstract

Altered function in the limbic-cortical-striatial-pallidal-thalamic (LCSPT) circuit has been implicated in the pathophysiology of major depressive disorder (MDD). This study evaluated volumetric differences in subcortical volumes between depressed subjects with MDD (N=142), subjects with MDD in remission (N=72), and healthy controls (N=169). Participants underwent magnetic resonance imaging (MRI) scanning, and subcortical volumes were extracted using FMRIB's Integrated Registration and Segmentation Tool (FIRST), University of Oxford, UK. The depressed MDD subjects exhibited significantly smaller volumes in the bilateral thalamus and hippocampus compared to control subjects, and the differences in the bilateral thalamus remained significant after controlling for total intracranial volume. In a smaller subset of healthy controls and depressed MDD subjects matched to the remitted MDD subjects, significant differences in volume were observed across groups in the bilateral thalamus, as well as the right lateralized caudate, hippocampus, and pallidum; these were primarily accounted for by differences between the depressed MDD subjects versus both the remitted and healthy subjects, though none of these changes remained significant after controlling for total intracranial volume (TIV). Volumetric reductions in the thalamus and hippocampus may contribute to dysfunction within subcortical-cortical networks, consistent with previous evidence of metabolic and hemodynamic abnormalities in these regions in MDD. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Depression; Magnetic resonance imaging; Morphometry

Mesh:

Substances:

Year:  2013        PMID: 23850106      PMCID: PMC3756884          DOI: 10.1016/j.pscychresns.2013.05.004

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  43 in total

1.  Absence of striatal volume differences between depressed subjects with no comorbid medical illness and matched comparison subjects.

Authors:  E J Lenze; Y I Sheline
Journal:  Am J Psychiatry       Date:  1999-12       Impact factor: 18.112

2.  Improved optimization for the robust and accurate linear registration and motion correction of brain images.

Authors:  Mark Jenkinson; Peter Bannister; Michael Brady; Stephen Smith
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

3.  Brain effects of antidepressants in major depression: a meta-analysis of emotional processing studies.

Authors:  Pauline Delaveau; Maritza Jabourian; Cédric Lemogne; Sophie Guionnet; Loretxu Bergouignan; Philippe Fossati
Journal:  J Affect Disord       Date:  2010-10-27       Impact factor: 4.839

4.  MRI study of thalamic volumes in bipolar and unipolar patients and healthy individuals.

Authors:  S C Caetano; R Sassi; P Brambilla; K Harenski; M Nicoletti; A G Mallinger; E Frank; D J Kupfer; M S Keshavan; J C Soares
Journal:  Psychiatry Res       Date:  2001-12-30       Impact factor: 3.222

5.  A Bayesian model of shape and appearance for subcortical brain segmentation.

Authors:  Brian Patenaude; Stephen M Smith; David N Kennedy; Mark Jenkinson
Journal:  Neuroimage       Date:  2011-02-23       Impact factor: 6.556

Review 6.  Episodic memory, amnesia, and the hippocampal-anterior thalamic axis.

Authors:  J P Aggleton; M W Brown
Journal:  Behav Brain Sci       Date:  1999-06       Impact factor: 12.579

7.  A quantitative magnetic resonance imaging study of caudate and lenticular nucleus gray matter volume in primary unipolar major depression: relationship to treatment response and clinical severity.

Authors:  S S Pillay; P F Renshaw; C M Bonello; B C Lafer; M Fava; D Yurgelun-Todd
Journal:  Psychiatry Res       Date:  1998-12-14       Impact factor: 3.222

8.  3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity.

Authors:  Y I Sheline
Journal:  Biol Psychiatry       Date:  2000-10-15       Impact factor: 13.382

Review 9.  Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies.

Authors:  Valentina Lorenzetti; Nicholas B Allen; Alex Fornito; Murat Yücel
Journal:  J Affect Disord       Date:  2009-02-23       Impact factor: 4.839

Review 10.  Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment.

Authors:  Helen S Mayberg
Journal:  Br Med Bull       Date:  2003       Impact factor: 4.291

View more
  26 in total

1.  Multimodal imaging reveals a complex pattern of dysfunction in corticolimbic pathways in major depressive disorder.

Authors:  Allison C Nugent; Cristan Farmer; Jennifer W Evans; Sam L Snider; Dipavo Banerjee; Carlos A Zarate
Journal:  Hum Brain Mapp       Date:  2019-06-09       Impact factor: 5.038

2.  Volumetric brain differences in clinical depression in association with anxiety: a systematic review with meta-analysis.

Authors:  Daniela A Espinoza Oyarce; Marnie E Shaw; Khawlah Alateeq; Nicolas Cherbuin
Journal:  J Psychiatry Neurosci       Date:  2020-11-01       Impact factor: 6.186

3.  The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder.

Authors:  Mark J Niciu; Nicolas D Iadarola; Dipavo Banerjee; David A Luckenbaugh; Minkyung Park; Marc Lener; Lawrence Park; Dawn F Ionescu; Elizabeth D Ballard; Nancy E Brutsche; Nirmala Akula; Francis J McMahon; Rodrigo Machado-Vieira; Allison C Nugent; Carlos A Zarate
Journal:  J Psychopharmacol       Date:  2017-10-17       Impact factor: 4.153

4.  Shank3 as a potential biomarker of antidepressant response to ketamine and its neural correlates in bipolar depression.

Authors:  Robin Ortiz; Mark J Niciu; Nada Lukkahati; Leorey N Saligan; Allison C Nugent; David A Luckenbaugh; Rodrigo Machado-Vieira; Carlos A Zarate
Journal:  J Affect Disord       Date:  2014-10-16       Impact factor: 4.839

5.  Longitudinal brain volume changes in major depressive disorder.

Authors:  Dilara Yüksel; Jennifer Engelen; Verena Schuster; Bruno Dietsche; Carsten Konrad; Andreas Jansen; Udo Dannlowski; Tilo Kircher; Axel Krug
Journal:  J Neural Transm (Vienna)       Date:  2018-08-27       Impact factor: 3.575

Review 6.  Of mice and men: modelling post-stroke depression experimentally.

Authors:  G Kronenberg; K Gertz; A Heinz; M Endres
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 7.  Computational meta-analysis of statistical parametric maps in major depression.

Authors:  Danilo Arnone; Dominic Job; Sudhakar Selvaraj; Osamu Abe; Francesco Amico; Yuqi Cheng; Sean J Colloby; John T O'Brien; Thomas Frodl; Ian H Gotlib; Byung-Joo Ham; M Justin Kim; P Cédric M P Koolschijn; Cintia A-M Périco; Giacomo Salvadore; Alan J Thomas; Marie-José Van Tol; Nic J A van der Wee; Dick J Veltman; Gerd Wagner; Andrew M McIntosh
Journal:  Hum Brain Mapp       Date:  2016-02-08       Impact factor: 5.038

8.  Examination of structural brain changes in recent suicidal behavior.

Authors:  Diane J Kim; Elizabeth A Bartlett; Christine DeLorenzo; Ramin V Parsey; Clinton Kilts; Ricardo Cáceda
Journal:  Psychiatry Res Neuroimaging       Date:  2020-10-24       Impact factor: 2.493

9.  Do manual and voxel-based morphometry measure the same? A proof of concept study.

Authors:  Niels K Focke; Sarah Trost; Walter Paulus; Peter Falkai; Oliver Gruber
Journal:  Front Psychiatry       Date:  2014-04-08       Impact factor: 4.157

10.  Adolescents with current major depressive disorder show dissimilar patterns of age-related differences in ACC and thalamus.

Authors:  Cindy C Hagan; Julia M E Graham; Roger Tait; Barry Widmer; Adrienne O van Nieuwenhuizen; Cinly Ooi; Kirstie J Whitaker; Tiago Simas; Edward T Bullmore; Belinda R Lennox; Barbara J Sahakian; Ian M Goodyer; John Suckling
Journal:  Neuroimage Clin       Date:  2015-01-07       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.